Brain Tumor Therapeutics: Global Markets to 2023

Published - Jan 2019| Code - PHM208A| Analyst - BCC Research Staff

Report Highlights

The global market for brain tumor therapeutics should grow from $1.1 billion in 2018 to reach $2.0 billion by 2023 at a compound annual growth rate (CAGR) of 12.9% for the period of 2018-2023.

Report Includes

  • 20 data tables and 40 additional tables
  • Comprehensive overview of the global market for brain tumor therapeutics within the pharmaceutical industry
  • Analyses of global market trends, with data from 2017, estimates for 2018, and projections of compound annual growth rates (CAGRs) through 2023
  • Country specific data and analysis for United States, Canada, Mexico, Japan, China, India, France, Germany, U.K., Italy, Spain and Middle East and Africa
  • Impact analysis of major drivers and restraints, and regional dynamics of the global brain tumor therapeutics markets and current trends within the industry
  • Company profiles of prominent players in the market, including Bristol-Myers Squibb Co., Eisai Co., Ltd., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., and Novartis International AG

Report Scope

This report provides an overview of the current and future global market potential for brain tumor therapeutics. It provides a detailed analysis and information about conventional treatment options, ongoing market trends and the future direction of the market with respect to brain tumor therapy. 

Inclusions

  • The report covers a detailed background of the disease state, along with epidemiological and demographic data, market segmentation by therapy (chemotherapy and targeted therapy), age group of patients (adult and pediatric brain tumors), end users (hospitals, cancer research institutes and medical universities) and a detailed regional market analysis including North America, Europe, Asia-Pacific and the rest of the world. 
  • The report provides information on newer treatment opportunities and cutting-edge research on therapeutics for brain tumors. It covers various types of treatment used in the field of neuro-oncology: surgery, chemotherapy, radiotherapy, targeted therapy and immunotherapy. 
  • A detailed analysis of agents used in the market for chemotherapy, immunotherapy and targeted therapy, as well as a pipeline analysis of newer molecules and therapeutics is covered in the report. 
  • A comprehensive analysis of market dynamics in the industry and current market trends are described in the report, along with the competitive landscape and discussion about key market players in the field of brain tumor therapeutics, where market strategies of these players are studied and described. The report includes a patent analysis of brain tumor therapeutics. 
  • The report concludes with company profiles of key players in the development and commercialization of brain tumor therapeutics. 
  • A separate chapter on emerging trends and breakthrough technologies in the field of neuro-oncology has been included in this report. 

Exclusions

Excluded from this report are the market size for equipment used in radiotherapy, surgical equipment and supplies and market size for drugs used for the symptomatic management of cancer (anti-epileptics, anti-emetics and hormonal medications). This report also excludes market size for immunotherapy. This is not a proven treatment for brain tumors and is currently being developed in research and clinical trials. 

Market values are provided for 2017 as base year, 2018 and forecast through 2023.Estimated values are based on manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Analyst Credentials

BCC Research Staff comprises expert analysts who are skilled in conducting primary research, secondary research and data analysis and have decades of combined experience covering a wide range of industries, including healthcare, advanced materials and emerging technologies. Collectively, the team represents a diverse set of educational achievements with individual graduate work completed in fields such as microbiology, electrical engineering, business administration and surgery, among others.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Note: Reports are discounted or included with certain Memberships. See Membership Options.
Title/Chapter Name Pages Price Member Price
Full Report: Brain Tumor Therapeutics: Global Markets to 2023 161 $5,500 Free
Chapter- 1: Introduction6Free DownloadFree
Chapter- 2: Summary and Highlights2$250Free
Chapter- 3: Disease Background and Overview24$830Free
Chapter- 4: Market Dynamics12$415Free
Chapter- 5: Market Breakdown by Therapy22$761Free
Chapter- 6: Market Breakdown by Patient Age14$484Free
Chapter- 7: Market Breakdown by End User5$173Free
Chapter- 8: Market Breakdown by Region14$484Free
Chapter- 9: Emerging Technologies and Future Trends6$208Free
Chapter- 10: Clinical Research in Brain Tumor Therapeutics9$311Free
Chapter- 11: Patent Review5$173Free
Chapter- 12: Competitive Landscape and Market Strategies9$311Free
Chapter- 13: Regulatory and Reimbursement Landscape10$346Free
Chapter- 14: Company Profiles21$726Free
Chapter- 15: Appendix: Acronyms2$69Free
 
RELATED REPORTS
Share This Report